Skip to main content

Find Clinical Trials

Home
Conditions
Potentially Resectable MET-altered Non-Small Cell Lung Cancer

Clinical trial condition

Potentially Resectable MET-altered Non-Small Cell Lung Cancer

Explore clinical trials studying Potentially Resectable MET-altered Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Potentially Resectable MET-altered Non-Small Cell Lung Cancer trial results

Not Yet Recruiting

Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

NCT06644313

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details